GNH USA

Europe — EMA

Olpress (Olmesartan Medoxomil)

Olmesartan medoxomil, the active ingredient in Olpress, is an angiotensin II receptor blocker presented as a tablet for oral use. It is used to manage high blood pressure in adult patients.

Request sourcing

1
Pack/s

What is Olmesartan Medoxomil?

Olmesartan medoxomil, the active ingredient in Olpress, is an angiotensin II receptor blocker presented as a tablet for oral use. It is used to manage high blood pressure in adult patients. GNH USA supplies Olpress as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olpress as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Olmesartan Medoxomil used for?

Olmesartan medoxomil is indicated for hypertension, a condition characterized by elevated arterial pressure.

- Hypertension: helps lower systolic and diastolic blood pressure to reduce cardiovascular risk. - Heart failure: used as part of combination therapy to improve cardiac output. - Diabetic nephropathy: provides renal protection by controlling blood pressure. - Post‑myocardial infarction: assists in stabil of blood‑pressure control after an MI event.

What are the side effects of Olmesartan Medoxomil?

The most         …  … ... ... ... ... … … … ... ...

What precautions apply to Olmesartan Medoxomil?

...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Olmesartan Medoxomil
Route
Oral Use
Manufacturer
Menarini International Operations Luxembourg S.A.
Origin
EU

Related products